Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Acad Pediatr. 2015 Sep 26;16(2):183–191. doi: 10.1016/j.acap.2015.06.014

Table 1.

List of Highest Decile of LASA Errors, Ranked by Potential Harm of Receiving the Delivered Drug in Error

Generic Name of Delivered Drug Published Name of Delivered Drug* Published Name of Intended Drug Generic Name of Intended Drug Average Harm Score No. of Subjects§
Potassium K Dur Kayexalate Sodium polystyrene sulfonate 93 0
Cyclosporine Cyclosporine Cyclophosphamide Cyclophosphamide 92 5
Digoxin Lanoxin Levothyroxine Levothyroxine 92 15
Warfarin Coumadin Cardura Doxazosin 91 5
Warfarin Jantoven Januvia Sitagliptin 90 1
Warfarin Warfarin Levaquin Levofloxacin 90 52
Warfarin Coumadin Mephyton Phytonadione 89 5
Warfarin Coumadin Avandia Rosiglitazone 88 2
Warfarin Jantoven Janumet Sitagliptin + Metformin 88 0
Azathioprine Azathioprine Azithromycin Azithromycin 87 63
Temozolomide Temodar Tambocor Flecainide 86 0
Cyclophosphamide Cyclophosphamide Cyclosporine Cyclosporine 85 5
Disopyramide Disopyramide Desipramine Desipramine 85 0
Lithium Eskalith Effexor Venlafaxine 85 99
Letrozole Femara Famvir Famciclovir 85 0
Labetalol Labetalol Albuterol Albuterol 85 40
Lithium Lithium Lanthanum Lanthanum 85 0
Amiodarone Amiodarone Amlodipine Amlodipine 84 3
Glipizide Glucotrol Detrol Tolterodine 84 1
Nitroglycerin Nitro Bid Macrobid Nitrofurantoin 84 5
Flecainide Tambocor Tamoxifen Tamoxifen 84 0
Alprazolam Xanax Atarax Hydroxyzine 84 430
Hydromorphone Hydromorphone Haloperidol Haloperidol 83 0
Levorphanol Levorphanol Levothyroxine Levothyroxine 83 0
Capecitabine Xeloda Xenical Orlistat 83 0
Anastrazole Arimidex Aromasin Exemestane 82 0
Clomipramine Clomipramine Clozapine Clozapine 82 1
Clomipramine Clomipramine Clomid Clomiphene 82 0
Cyclosporine Cyclosporine Cycloserine Cycloserine 82 0
Diazoxide Diazoxide Diamox Acetazolamide 82 0
Fludrocortisone Florinef Fioricet Butalbital + acetaminophen + caffeine 82 0
Methadone Methadone Methylphenidate Methylphenidate 82 9
Morphine Morphine Magnesium Sulfate Magnesium Sulfate 82 0
Nifedipine Nifedipine Nortriptyline Nortriptyline 82 1
Digoxin Lanoxin Lotensin Benazepril 81 18
Tamoxifen Nolvadex Flomax Tamsulosin 81 0
Amlodipine Amlodipine Amiodarone Amiodarone 80 3
Metoprolol Lopressor Lyrica Pregabalin 80 5
Amiodarone Pacerone Pancrease Pancrelipase 80 3
Midodrine ProAmatine Bromocriptine Bromocriptine 80 0
Tacrolimus Tacrolimus Tamsulosin Tamsulosin 80 0
Digoxin Lanoxin Lasix Furosemide 79 447
Chlorambucil Leukeran Leucovorin Leucovorin 79 0
Hydrocodone + Acetaminophen Lortab Loratadine Loratadine 79 8259
Loxapine Loxitane Soriatane Acitretin 79 0
Methotrexate Methotrexate Minoxidil Minoxidil 79 0
Procainamide Procanbid Probenecid Probenecid 79 0
Reserpine Reserpine Ropinirole Ropinirole 79 0
Rosiglitazone + Metformin Avandamet Anzemet Dolasetron 78 0
Chlorpromazine Chlorpromazine Clomipramine Clomipramine 78 2
Clozapine Clozaril Pletal Cilostazol 78 0
Digoxin Lanoxin Levsin Hyoscyamine 78 24
Methadone Methadone Mephyton Phytonadione 78 1
Methimazole Methimazole Metaxalone Metaxalone 78 6
Nitroglycerin Nitroglycerin Nitrofurantoin Nitrofurantoin 78 5
Sitagliptin + Metformin Janumet Jantoven Warfarin 77 0
Theophylline Slow Bid Slow K Potassium 77 0
Hydrocodone + Acetaminophen Vicodin Vytorin Ezetimibe + simvastatin 77 20
Digoxin Lanoxin Lomotil Diphenoxylate + atropine 76 7
Digoxin Lanoxin Levaquin Levofloxacin 76 24

LASA indicates look alike, sound alike.

Bold type indicates that LASA pair is in highest decile for potential harm for receiving delivered drug in error and highest decile for potential harm of not receiving intended drug. Brand names appear in italic type.

*

Delivered drug indicates drug received in error.

Intended drug indicates drug patient was supposed to receive.

Average harm score represents the average of round 3 evaluations of the opinion-generated estimate of the harm that might occur from this substitution, where patient received delivered drug instead of intended drug.

§

Number of subjects in 2000–2009 data who received both drugs in respective LASA pair within 6-month period, regardless of whether this was intended or in error. Each occurrence represents potential LASA substitution error.